Mitch C. Hill - 01 Oct 2024 Form 4 Insider Report for Inari Medical, Inc.

Role
Chief Financial Officer
Signature
/s/ Shannon Trevino, attorney-in-fact for Mitch C. Hill
Issuer symbol
N/A
Transactions as of
01 Oct 2024
Net transactions value
-$83,982
Form type
4
Filing time
02 Oct 2024, 19:25:17 UTC
Previous filing
13 Sep 2024
Next filing
05 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Tax liability $13,449 -331 -0.18% $40.63 179,269 01 Oct 2024 Direct F1
transaction NARI Common Stock Tax liability $25,028 -616 -0.34% $40.63 178,653 01 Oct 2024 Direct F2
transaction NARI Common Stock Tax liability $26,897 -662 -0.37% $40.63 177,991 01 Oct 2024 Direct F3
transaction NARI Common Stock Tax liability $18,609 -458 -0.26% $40.63 177,533 01 Oct 2024 Direct F4
holding NARI Common Stock 1,600 01 Oct 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Mitch C. Hill is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
F2 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
F3 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
F4 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.